The Oncology Institute, Inc.

Q2 2023 13F Holders

Symbol
STLN
CUSIP
68236X100
Type
Equity
Class
COM
Num filings
40
Total reported value, excl. options
$7.66 M
Manager Report Date Value ($000) Shares Option Type